Clinical trial information as a measure of quality cancer care.
Participation in clinical trials enables patients to access new treatment options. Evidence shows improved outcomes in participants compared with nonparticipants in non-small-cell, lung, breast, colorectal, and testicular cancers.
Chua
Wei
W
Department of Medical Oncology, Sydney Cancer Centre, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
Clarke
Stephen J
SJ
J Clin Oncol. 2006 Jul 20;24(21):3498-9
16751437
J Clin Oncol. 1998 Apr;16(4):1628-30
9552076
Evid Rep Technol Assess (Full Rep). 2006 May;(138):1-116
17764215
Cancer. 2001 Jun 15;91(12):2246-57
11413512
Lancet. 1996 Apr 13;347(9007):1000-3
8606561
J Oncol Pract. 2006 Jan;2(1):26-30
20871730
J Clin Oncol. 2008 May 20;26(15):2562-7
18390967
J Clin Oncol. 2005 Sep 1;23(25):6233-9
16087948
J Clin Oncol. 2004 Aug 1;22(15):2985-91
15284249
Cancer. 2009 Oct 15;115(20):4679-87
19562777
J Clin Oncol. 1994 Feb;12(2):368-77
7509384
Cancer. 1985 Oct 1;56(7):1710-8
3896460